Avanthay, Mickaël http://orcid.org/0000-0001-9710-2182
Bedford, Robin B. http://orcid.org/0000-0002-8021-8768
Begg, Callum S. http://orcid.org/0000-0002-8727-3444
Böse, Dietrich
Clayden, Jonathan http://orcid.org/0000-0001-5080-9535
Davis, Sean A.
Eloi, Jean-Charles
Goryunov, Georgy P. http://orcid.org/0000-0002-5188-5799
Hartung, Ingo V. http://orcid.org/0000-0001-8750-679X
Heeley, Joseph http://orcid.org/0000-0002-1371-1747
Khaikin, Kirill A.
Kitching, Matthew O. http://orcid.org/0000-0001-8276-583X
Krieger, Johannes
Kulyabin, Pavel S. http://orcid.org/0000-0003-2548-2117
Lennox, Alastair J. J. http://orcid.org/0000-0003-2019-7421
Nolla-Saltiel, Roberto http://orcid.org/0000-0003-4034-8485
Pridmore, Natalie E.
Rowsell, Benjamin J. S. http://orcid.org/0000-0001-7209-4382
Sparkes, Hazel A.
Uborsky, Dmitry V.
Voskoboynikov, Alexander Z. http://orcid.org/0000-0002-7131-7588
Walsh, Mark P. http://orcid.org/0000-0003-3185-2460
Wilkinson, Harry J. http://orcid.org/0000-0001-9961-3605
Funding for this research was provided by:
GlaxoSmithKline
RCUK | Engineering and Physical Sciences Research Council (EP/R027129/1, EP/S018050/1, EP/T518001/1, EP/S024107/1, grant EP/R027129/1, EP/S018050/1, grant EP/R027129/1, EP/S018050/1, EP/L015366/1)
EC | Horizon 2020 Framework Programme (Advanced Grant 883786, Advanced Grant 883786)
Royal Society (UF150536, RGS\R2\180467)
Article History
Received: 18 March 2021
Accepted: 30 September 2021
First Online: 2 December 2021
Competing interests
: The authors declare no competing interests.